打开APP
userphoto
未登录

开通VIP,畅享免费电子书等14项超值服

开通VIP
Researchers discover novel factor in Parkinson's disease: Discovery may lead to better understanding

A team of local researchers have discovered a previously unknown cellular defect in patients with idiopathic Parkinson's disease, and identified a sequence of pathological events that can trigger or accelerate premature death of certain neurons in the brain seen in this disease.

The findings, published in the journal Nature Communications, will provide a better understanding and further research towards a possible cure of Parkinson's disease, which is a neurodegenerative disorder that affects movement and other vital functions in nearly one million people in the United States. Despite advances in understanding the causes of familial forms of this disease, the most prevalent idiopathic form of Parkinson's disease remains a mystery.

Boston University School of Medicine (BUSM) researchers discovered that the cells of people with idiopathic Parkinson's disease have a previously unknown defect in the function of a specific PLA2g6 protein, causing dysfunction of calcium homeostasis that can determine whether some cells will live or die.

'Idiopathic or genetic dysfunction of calcium signaling triggers a sequence of pathological events leading to autophagic dysfunction, progressive loss of dopaminergic neurons and age-dependent impairment of vital motor functions typical for Parkinson's disease,' explained corresponding author Victoria Bolotina, PhD, professor of medicine at BUSM.

'Discovery of this new mechanism associated with human Parkinson's disease and our ability to mimic this pathology in a novel genetic model opens new opportunities for finding a cure for this devastating neurodegenerative disease,' she added.


Story Source:

The above post is reprinted from materials provided by Boston University Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Qingde Zhou, Allen Yen, Grzegorz Rymarczyk, Hirohide Asai, Chelsea Trengrove, Nadine Aziz, Michael T. Kirber, Gustavo Mostoslavsky, Tsuneya Ikezu, Benjamin Wolozin, Victoria M. Bolotina. Impairment of PARK14-dependent Ca2 signalling is a novel determinant of Parkinson’s disease. Nature Communications, 2016; 7: 10332 DOI: 10.1038/ncomms10332

Cite This Page:

Boston University Medical Center. 'Researchers discover novel factor in Parkinson's disease: Discovery may lead to better understanding of disease, early diagnosis and therapeutic development.' ScienceDaily. ScienceDaily, 12 January 2016. <www.sciencedaily.com/releases/2016/01/160112113614.htm>.
Boston University Medical Center. (2016, January 12). Researchers discover novel factor in Parkinson's disease: Discovery may lead to better understanding of disease, early diagnosis and therapeutic development. ScienceDaily. Retrieved January 15, 2016 from www.sciencedaily.com/releases/2016/01/160112113614.htm
Boston University Medical Center. 'Researchers discover novel factor in Parkinson's disease: Discovery may lead to better understanding of disease, early diagnosis and therapeutic development.' ScienceDaily. www.sciencedaily.com/releases/2016/01/160112113614.htm (accessed January 15, 2016).

本站仅提供存储服务,所有内容均由用户发布,如发现有害或侵权内容,请点击举报
打开APP,阅读全文并永久保存 查看更多类似文章
猜你喜欢
类似文章
【热】打开小程序,算一算2024你的财运
国际帕金森病遗传协会10周年:帕金森病基因组研究进展与展望
考研英语阅读理解精读100篇unit94
帕金森患者的用药思路
更便宜、更简单、更有效:治疗老年帕金森病患者的技巧
衡生活 成立啦!
了解阿茲海默症Understanding Alzheimer's Disease
更多类似文章 >>
生活服务
热点新闻
分享 收藏 导长图 关注 下载文章
绑定账号成功
后续可登录账号畅享VIP特权!
如果VIP功能使用有故障,
可点击这里联系客服!

联系客服